ADC Therapeutics ADCT
NYSE ADCT
$1.60 +0.10 (+6.67%)
As of: Oct 22, 2026 · 3:59 PM EDT

ADC Therapeutics (ADCT) EBT (2020 - 2026)

Updated

ADC Therapeutics (ADCT) recorded EBT of -$16.57 million in Q2 2026, compared with -$55.39 million a year earlier.

Analysis

ADC Therapeutics (ADCT) EBT (2020 - 2026) Analysis & Trends

On a TTM basis, ADC Therapeutics' EBT came in at -$145.89 million as of Jun 30, 2026.

  • The Q2 2026 figure is the highest quarterly EBT in data going back to Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 9.25 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 34.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 4.28 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -683.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 2.80 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 2.77 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -10.25 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -653.00 Mn
10 ADC Therapeutics 247.25 Mn -698.94 Mn 16.90 Mn -16.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -16.57 Mn
Mar 31, 2026 -32.97 Mn
Sep 30, 2025 -40.97 Mn
Jun 30, 2025 -55.39 Mn
Mar 31, 2025 -38.44 Mn
Sep 30, 2024 -43.62 Mn
Jun 30, 2024 -35.71 Mn
Mar 31, 2024 -45.80 Mn
Sep 30, 2023 -45.40 Mn
Jun 30, 2023 -52.70 Mn
Mar 31, 2023 -59.69 Mn
Sep 30, 2022 -51.32 Mn
Jun 30, 2022 -65.32 Mn
Mar 31, 2022 -17.83 Mn
Sep 30, 2021 -71.40 Mn
Jun 30, 2021 -72.33 Mn
Mar 31, 2021 -51.42 Mn
Sep 30, 2020 -20.33 Mn
Jun 30, 2020 -126.45 Mn
Mar 31, 2020 -43.38 Mn
API Access

ADC Therapeutics EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=ADCT&period=max&api_key=YOUR_API_KEY